Home > Boards > US OTC > Medical - Drugs >

Ocuphire Pharma Inc (OCUP)

OCUP RSS Feed
Add OCUP Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/29/2021 7:50:49 AM - Followers: 5 - Board type: Free - Posts Today: 0

A Clear Focus on Eye Disorders

Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders.

Targeting Front and Back of the Eye Indications

Our pipeline currently includes two small-molecule product candidates targeting front and back of the eye indications.

Nyxol® Eye Drops

Our lead product candidate, Nyxol® Eye Drops, is a once-daily preservative-free eye drop formulation of phentolamine mesylate, a non-selective alpha-1 and alpha-2 adrenergic antagonist designed to reduce pupil size and improve visual acuity. Nyxol is being developed for several indications, including dim light or night vision disturbances, pharmacologically-induced mydriasis, and presbyopia.

Nyxol is an investigational 505(b)(2) product candidate that has been studied in over 230 subjects across 7 completed Phase 1 and 2 trials.

SEE NYXOL CLEARER

APX3330

Our second product candidate, APX3330, is a twice-a-day oral tablet designed to inhibit angiogenesis and inflammation pathways relevant to retinal and choroidal vascular diseases, such as diabetic retinopathy and diabetic macular edema.

APX3330 has been studied  in over 440 patients across six Phase 1 and five Phase 2 trials.

SEE APX3330 CLEARER

Clinical Trials with a Broad Range of View

We plan to initiate two Phase 3 registration trials and two Phase 2 trials across four ophthalmic indications in the fourth quarter of 2020 through the first quarter 2021.

VIEW OUR TRIALS

Aligning Our Vision with Partners

As part of our strategy, we continue to explore opportunities to acquire additional ophthalmic assets and to seek strategic partners for late-stage development, regulatory preparation and commercialization of drugs in key global markets.

PARTNERSHIP OPPORTUNITIES

Leadership in Drug Development

Our leadership team is comprised of seasoned professionals with decades of experience in the pharmaceutical, biotech and medical research industries. Meet our teams.

 
OCUP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OCUP News: Ocuphire Pharma EPS beats by $0.36 05/07/2021 08:49:31 AM
OCUP News: Ocuphire Announces Financial Results for the First Quarter 2021 and Provides Corporate Update 05/07/2021 08:00:00 AM
OCUP News: Ocuphire’s APX3330 for Retinal Diseases to be Presented at the 2021 Association for Research in Vision and Ophthalmology (A... 04/22/2021 08:00:00 AM
OCUP News: Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy 04/08/2021 08:31:26 AM
OCUP News: Ocuphire’s opportunity in mydriasis reversal is underappreciated: Cantor Fitzgerald 03/15/2021 01:11:43 PM
News News Alert: Ocuphire Pharma EPS beats by $0.36 05/07/2021 08:49:31 AM
PostSubject
#23   OCUP PT $20 was issued this month now alchemytrader 03/29/21 07:50:49 AM
#22   One of the best development pipelines in ophthalmology biotrader1212 03/27/21 03:38:01 PM
#21   I bought in at $4.832. My portfolio is StockFOXXX 01/25/21 01:51:20 PM
#20   Man o man....she’s a blowing and going. She’ll StockFOXXX 01/20/21 01:11:13 PM
#19   all I can say weeeeeee paytience pays off! Screech691 01/20/21 10:13:33 AM
#18   Ouch. Not a great week for OCUP. Hoping StockFOXXX 01/13/21 02:58:22 PM
#17   $OCUP how do you not love this chart, Screech691 01/06/21 08:22:37 AM
#16   moved above the 50 DMA - 200 DMA Screech691 01/05/21 11:16:48 AM
#15   crazy how easy it moves, might see some Screech691 01/04/21 04:11:11 PM
#14   Boy oh boy. Wonder how high this can go StockFOXXX 01/04/21 03:23:55 PM
#13   Yup looking real good Screech691 12/31/20 08:29:13 AM
#12   Case in point today StockFOXXX 12/30/20 11:47:06 PM
#11   I have seen very few stocks trade this Screech691 12/15/20 05:11:43 PM
#10   I love this stock. It gains tens of StockFOXXX 12/15/20 04:28:18 PM
#9   yeah it's crazy, my average is $6.15 now Screech691 12/14/20 04:00:20 PM
#8   I’m surprised this is not on anyone’s radar. StockFOXXX 12/14/20 03:44:48 PM
#7   I hope we go green. It would be StockFOXXX 12/14/20 03:44:04 PM
#6   in this one, possibly could see news Monday....micro floater Screech691 12/11/20 11:49:37 AM
#5   New floor is in and we keep up. StockFOXXX 12/07/20 03:29:09 PM
#4   Chart holding steady. New price floor is developing StockFOXXX 12/02/20 12:26:39 AM
#3   ***NEWS NEWS NEWS*** Ocuphire Pharma, Inc., (NASDAQ:OCUP) a clinical-stage StockFOXXX 11/19/20 09:31:35 AM
#2   $OCUP retracing and building new support level. Should StockFOXXX 11/18/20 03:30:59 PM
#1   Welcome to the OCUPHIRE PHARMA INC board (OCUP)!! StockFOXXX 11/17/20 10:20:53 PM
PostSubject
Consent Preferences